ALERTS & COVID-19 UPDATES Learn more: COVID-19 Resources; COVID-19 Testing; Vaccine Info; Safe Care; Visitor Policy; Support Us, DPH Attestation & Phase 3 Information

Back to Clinical Trials
Protocol #: 2016-063
Principal Investigator(s): Timothy Liesching, MD
Study Coordinator(s): Yuxiu Lei
Trial Phase: Registry
Gender: Male / Female

[LCID Study Number: 2016-063]

Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry

The overall goal of this registry is to collect data and biological samples that will support future research studies.

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-2940